Kalydeco 150 MG tablet 56S
Ended Awarded
- Contract number
- SPE2DB25FSZ60
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,978
Award facts
- Contract value 100% obligated
- $36,978.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on September 3, 2025, for Kalydeco 150 mg tablets (56-count units). The contract, valued at $36,978.00 with an ultimate completion date of September 4, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive portfolio of pharmaceutical products supporting military healthcare facilities worldwide.
Kalydeco is a cystic fibrosis treatment medication, and this delivery order represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company's strategic positioning as a women-owned small business has enabled it to secure consistent federal contracts across a diverse range of specialty pharmaceuticals, branded and generic prescription drugs, and medical consumables. The firm fixed-price structure ensures predictable costs while supporting the Defense Logistics Agency's medical supply requirements for Department of Defense healthcare sites globally.
Quick answers
Who was awarded contract SPE2DB25FSZ60?
SPE2DB25FSZ60 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FSZ60 worth?
The government has obligated $36,978 on SPE2DB25FSZ60.
Is contract SPE2DB25FSZ60 an order under another contract?
Yes. SPE2DB25FSZ60 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ60 competed?
The extent of competition for SPE2DB25FSZ60 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award